Pharmafile Logo
Pharmafocus logo
Advanced Search

Merck

Showing 15 posts of 360 posts found.

keytruda3-web

MSD’s Keytruda receives green light from NICE for NHS use

October 12, 2015
Sales and Marketing MSD, Merck, NICE, keytruda, melanoma, pembrolizumab, skin cancer

The UK healthcare watchdog NICE has recommended Keytruda as a treatment for advanced skin cancer – its second endorsement of …

News
merckincweb

NICE approves Merck’s Keytruda for advanced skin cancer following ipilimumab treatment

October 7, 2015
Research and Development Merck, NHS, NICE, keytruda, skin cancer

The National Institute for Health and Care Excellence (NICE) has approved Merck’s Keytruda (pembrolizumab) for treating advanced skin cancer after …

News
velocity_health

Merck and Wayra to tackle NHS funding gap with startup rewards programme

September 25, 2015
Research and Development MSD, Merck

Merck Sharpe and Dohme (MSD) and Wayra Open Future, Telefonica’s digital start up accelerator, are investing in digital innovation in …

News
keytruda

NICE recommends Keytruda for advanced skin cancer

September 7, 2015
Research and Development, Sales and Marketing Merck, NICE, keytruda, skin cancer

NICE has approved Merck’s Keytruda (pembrolizumab) as a treatment for advanced skin cancer in final draft guidance for the NHS.  …

News
Advanced melanoma

Novartis and Merck skin cancer drugs move through pipeline

August 20, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Merck, Novartis, Odomzo, basal cell carcinoma, keytruda, melanoma, pembrolizumab, skin cancer, sonidegib

Both Novartis and Merck have hit regulatory milestones with their skin cancer drugs in the EU and the US. Novartis’ …

News
Keytruda image

Merck in immuno-oncology collaboration with major cancer research centre

August 14, 2015
Research and Development Cancer, Merck, keytruda, oncology

Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …

News

David Khougazian announced as president of Sanofi Pasteur MSD

July 29, 2015
Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur

Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …

Appointment

EU approval for new Sanofi, Merck vaccine

June 18, 2015
Sales and Marketing EU, Europe, Merck, Sanofi, Sanofi pasteur msd, brett wells, gardasil 9

Sanofi and Merck are looking forward to a successor to their blockbuster Gardasil now that the European Commission has granted …

News
Januvia image

Merck diabetes drug gets CV trial boost

June 9, 2015
Research and Development, Sales and Marketing Januvia, Merck, cv, diabetes, sitagliptin

Merck’s diabetes drug Januvia has been given a boost following worries over side effects for patients after a trial revealed …

News
Merck logo

Merck launches new antibiotic in the UK

June 5, 2015
Research and Development, Sales and Marketing AMR, Antibiotics, MSD, Merck, Sivextro, antimicrobial resistance, cubist, tedizolid phosphate

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …

News
Keytruda image

Merck tests new Keytruda combination

June 3, 2015
Research and Development, Sales and Marketing Merck, dynavax, keytruda

Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …

News
EMA image

EMA recommends eight drugs for approval

May 22, 2015
Sales and Marketing Amgen, BMS, EMA, Janssen, Merck, keytruda

The EMA has recommended eight medicines for approval in a round of reviews, including four new cancer indications. Amgen’s Repatha …

News

Merck KGaA’s sales climb but key drugs fall

May 19, 2015
Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif

Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …

News

Merck KGaA reveals ASCO plans

May 15, 2015
Sales and Marketing ASCO, Merck, Merck KGaA, Merck Serono, avelumab

Merck KGaA is the latest company to announce its slate for this year’s ASCO conference, and like other firms it …

News
Merck image

Merck to test Keytruda combinations

May 8, 2015
Sales and Marketing BMS, Daiichi Sankyo, Merck, Plexxikon, keytruda, pembrolizumab

Merck will be teaming up with Daiichi Sankyo’s subsidiary Plexxikon to investigate immunotherapy combinations in cancer. A collaborative clinical trial …

News

Latest content

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024

EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention

July 1, 2024

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024